Joseph C. Ratliff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joseph C. Ratliff has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Cenk Tek
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States
3 shared publicationsErin L. Reutenauer
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States
3 shared publicationsLaura B. Palmese
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States
3 shared publicationsCarlos M. Grilo
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States
1 shared publicationEllen Liskov
Yale-New Haven Hospital, New Haven, CT, United States
1 shared publicationJessica A. Barber
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
1 shared publication
Latest Publications
- 1 January 2013
- Published by Elsevier in Psychosomatics
- Vol. 54 (1) , 67-73
Obese Schizophrenia Spectrum Patients Have Significantly Higher 10-Year General Cardiovascular Risk and Vascular Ages than Obese Individuals without Severe Mental Illness
- 1 January 2013
- Published by Elsevier in Psychosomatics
- Vol. 54 (1) , 67-73
Obese Schizophrenia Spectrum Patients Have Significantly Higher 10-Year General Cardiovascular Risk and Vascular Ages than Obese Individuals without Severe Mental Illness
- 1 October 2012
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 53 (7) , 1028-1033
The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study
- 1 October 2012
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 53 (7) , 1028-1033
The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study
- Open Access
Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey
The incidence of obesity in the United States has reached epidemic proportions. Previous research has shown several medications exert noticeable effects on body‐weight regulation. Histamine‐1 (H1) receptor blockers commonly used to alleviate allergy symptoms are known to report weight gain as a possible side effect. Therefore, we investigated the association between prescription H1 antihistamine use and obesity in adults using data from the 2005–2006 National Health and Nutrition Examination Survey (NHANES). Adults taking prescription H1 antihistamines were matched by age and gender with controls and compared on the basis of body measurements, plasma glucose, insulin concentrations, and lipid levels. Prescription H1 antihistamine users had a significantly higher weight, waist circumference, and insulin concentration than matched controls. The odds ratio (OR) for being overweight was increased in prescription H1 antihistamine users. H1 antihistamine use may contribute to the increased prevalence of obesity and the metabolic syndrome in adults given these medications are also commonly used as over‐the‐counter remedies.
Open AccessAssociation of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey
The incidence of obesity in the United States has reached epidemic proportions. Previous research has shown several medications exert noticeable effects on body‐weight regulation. Histamine‐1 (H1) receptor blockers commonly used to alleviate allergy symptoms are known to report weight gain as a possible side effect. Therefore, we investigated the association between prescription H1 antihistamine use and obesity in adults using data from the 2005–2006 National Health and Nutrition Examination Survey (NHANES). Adults taking prescription H1 antihistamines were matched by age and gender with controls and compared on the basis of body measurements, plasma glucose, insulin concentrations, and lipid levels. Prescription H1 antihistamine users had a significantly higher weight, waist circumference, and insulin concentration than matched controls. The odds ratio (OR) for being overweight was increased in prescription H1 antihistamine users. H1 antihistamine use may contribute to the increased prevalence of obesity and the metabolic syndrome in adults given these medications are also commonly used as over‐the‐counter remedies.